President Donald Trump’s pick to lead the US Food and Drug Administration told senators in a tense confirmation hearing Thursday that, if confirmed as FDA commissioner, he plans to evaluate school lunches,

Dr. Marty Makary, Trump's nominee to lead the FDA, said he would review a Biden-era rule that allowed patients to obtain mifepristone without seeing a health care provider in person.

Dr. Marty Makary, President Trump's nominee to lead the Food and Drug Administration, faced questions from senators about access to an abortion pill, mifepristone, and if he would review its availability.